Income Statement
JADE BIOSCIENCES, INC.
JBIO
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - |
|
Operating Expenses
|
113.54 | 74.60 | 81.41 | 53.24 | 23.02 |
|
Research & Development
|
93.12 | 53.19 | 64.22 | 38.62 | 14.99 |
|
Selling, General & Administrative
|
20.42 | 21.41 | 17.19 | 14.62 | 8.04 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-113.54 | -74.60 | -81.41 | -53.24 | -23.02 |
|
Non-Operating Income
|
-13.81 | 5.02 | -5.94 | -1.75 | -0.06 |
|
Interest Income
|
- | - | - | - | - |
|
Interest Expense
|
- | - | - | - | - |
|
Other Non-Op Income / Expense
|
-0.01 | -0.02 | 5.94 | 1.75 | 0.06 |
|
Income Before Tax
|
-127.35 | -69.57 | -75.47 | -51.49 | -22.96 |
|
Income Tax Expense
|
0.06 | 0.06 | 0.06 | 0.03 | 0.00 |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-127.41 | -69.63 | -75.52 | -51.51 | -22.96 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-113.54 | -74.60 | -81.41 | -53.24 | -23.02 |
|
Earnings Per Share (Basic)
|
-3.19 | -2.44 | -2.87 | -2.10 | - |
|
Diluted EPS
|
-3.19 | -2.44 | -2.87 | -2.10 | - |
|
Weighted Average Shares
|
31.36 | 28.58 | 26.33 | 24.47 | - |
|
Diluted Weighted Avg Shares
|
31.36 | 28.58 | 26.33 | 24.47 | - |
|
Comprehensive Income
|
-127.28 | -69.76 | -74.82 | -51.92 | -23.02 |